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Pulmonary oat cell carcinoma was first described
in 1926 and constitutes around 25% of lung
malignancy.' Dugoid et al reported the first case
of extrapulmonary oat cell carcinoma, without
any bronchial involvement, in 1930.2 Primary
extrapulmonary oat cell tumours have since been
reportedoriginatingfromdifferentorgansexceptthe
liverandthe centralnervous system. Wereporttwo
casesofprimaryextrapulmonaryoatcellcarcinoma
andhavereviewedtheliteratureofthisrarecondition
with regard to prognosis andtreatment.
The history of each patient was reviewed and a
relevant summary made. A literature review was
performed using Medline. The key words "oat
cell carcinoma", "extrapulmonary" and "small
cell carcimona" were used and the results of the
search correlated. The current recommendations
fortreatment were also reviewed.
CTscanofhischestandabdomenconfirmedamass
lesionmeasuring3 x2cmarisingfromtheposterior
wallofthestomach.Nolymphadenopathy,metastatic
diseaseorbronchialinvolvementwasdemonstrated,
although not confirmed by bronchoscopy. At
laparotomy, the tumour was unresectable due to
extensive involvementwiththe leftlobe ofthe liver
and pancreas. The patient received two doses of
adjuvant vincristine and etoposide but his general
condition deteriorated and he died three months
after surgery.
CASE 2 A 39-year-old female, who also was a
non-smoker, presented with symptoms of gastric
outlet obstruction. OGD revealed a necrotic
ulcerating tumour in the duodenum, biopsies of
which suggested a small cell carcinoma. A CT
scan showed a 6 cm soft tissue mass in the second
part of the duodenum, displacing the pancreas
CASE 1 A 70-year-old man, who was a
non-smoker, presented with a one-year history of
passing dark stools and an eight-week history of
anorexia, weight loss and early satiety. Physical
examination revealed a palpable epigastric mass.
He was anaemic (Hb level of 7.9g/dl and mean
cellvolume 83.8g/1), while liverfunctiontests and
carcinoembryonic antigen were normal.
Oesophagogastroduodenoscopy (OGD) showed an
ulceratedpolypoidlesioninthebodyofthestomach.
Biopsy revealed a small round blue cell tumour.
Furtherimmunohistologicalstudiesshowedastrong
positive reaction for neuroendocrine marker PGP
9.5.Anabsenceofstainingwasnotedwithvimentin,
lymphoidandepithelialmarkers,whichoverallwas
suggestive ofoat cell carcinoma.
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anteriorly. No lymphadenopathy or pulmonary or
hepatic lesions werenoted, althoughnotconfirmed
by bronchoscopy.
At laparotomy the tumour was inoperable and
a palliative gastrojejunostomy was fashioned
and a stent inserted into the common bile duct.
Histopathology of both the OGD biopsy and a
lymph node obtained atthe time ofthe laparotomy
showed apoorlydifferentiatedtumourwitha small
cell appearance. It stained positive for CD56 and
P53 and PGP9.5, but stained negative for insulin
and somatostatin. Chemotherapy was commenced
using etoposide and cisplatin, but her condition
deteriorated and she died three and a halfmonths
after surgery.
DISCUSSION
Oat cell carcinoma ofthe lung is very aggressive,
metastasiseswidelyandisrarelycurablebysurgery.
This form oflungcanceroccurs mostlyin smokers
andhas ahigherincidence inminers withprevious
exposure to uranium or radium. The prognosis of
pulmonary oat cell cancer is poor with a median
survival ofabout one year and a five-year survival
of about 10% in spite of aggressive treatment.3
Extra-pulmonary oat cell cancers originating from
neuroendocrine cells are biologically aggressive
and associated with a poor prognosis.4 The two
cases ofextra-pulmonary oat cell cancer reported
here represent neuroendocrine tumours offoregut
origin.'
Gastric small cell carcinoma was first reported in
1976with66casesreportedsince.6 Thepresentation
isusuallyatalatestage,asdemonstratedinourcase.7
Thetumourisusuallypolypoidinappearance atthe
earlystage,progressingtocrater-likeulcerationdue
to rapid proliferation. The aggressive nature ofthe
tumour and relative insensitivity to chemotherapy
resultinfewlong-termsurvivorsandsurgicalefforts
are generally palliative.8
Duodenaloatcellcarcinomaisrare,withninecases
previouslyreportedinthe literature. Zamboniet al
reported three cases of small cell carcinoma in
the ampullary region ofthe duodenum.9 The poor
prognosis of oat cell tumours was again reflected
in these three cases with a median survival period
often months.
Histologicallythecellsgrowinclustersthatexhibit
neither granular nor squamous organisation. It
has been shown that the argentaffin (Kultchisky)
cells in the gut closely resemble cells contained in
normal bronchial mucosa.5 Electron microscopy
shows that these cells contain membrane-bound
densecoregranulescharacteristicofAPUD(Amine
Precursor Uptake and Decarboxylation) cells.
Similar granules are found in bronchial carcinoids
and oat cell carcinomas suggesting thatthey are of
APUDcellorigin.TheAPUDcellsystemisafamily
ofcells with similarcytological andultrastructural
features derived from the neuroectoderm. During
embryological neuralation, when the neural folds
elevate and fuse together, cells atthe lateral border
oftheneuroectodermbegintodissociate fromtheir
neighbouringcells.Thiscellpopulationwillundergo
epithelialtomesenchymaltransitionasitleavesthe
neuroectodermbyactivemigrationanddisplacement
to enter the underlying mesoderm. Among other
places they enter the gastrointestinal tract. These
APUD cells are responsible for the production of
polypeptidehormonesandbiologicallyactiveamines.
Thepresenceoftheneuroendocrinegranulesresults
inthepositivestainingofimmunohistochemicalcell
stains for neuroendocrine markers.
Radical surgery does not have a primary role in
managing extra-pulmonary oat cell cancer, as
the benefit is limited.'0 Any additional benefit of
radiotherapy is not adequate tojustify its potential
toxicity."I Multi-agent chemotherapy in different
combinationshassomesuccess,achievingacomplete
response rate (defined as 50% orgreater shrinkage
ofmeasurabledisease)rangingbetween21-91%.1,112
However,thesearenon-comparativeclinicalstudies
with small numbers of patients and-the median
survival still remains poor at 18-51 weeks.'2 An
analysisofthedifferentchemotherapeuticregimens
used suggests best results with a combination of
cisplatinandetoposidewithresponseratesreaching
70%, while doxorubicin-based regimens appear
to be less active.1314' 15 Complete response has
been observed with cisplatin and etoposide based
treatment in a patient with widespread metastatic
disease.'6ThetwopatientsreportedbyvanderGaast
hadextensivediseasewithareportedsurvivalof11
and16monthsaftercombinationchemotherapywith
cyclophosphamide, doxorubicin and etoposide.'7
Anotherpatientwithpancreatic oat cell carcinoma
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reported by Wahid survived 14 months with
combination chemotherapy andradiotherapy.18
In summary, primary extra-pulmonary oat cell
carcinomaisrareandoriginatesfromneuroendocrine
APUDcells.Itisessentialtoobtainanearlyaccurate
diagnosis so that appropriate treatment can be
commenced. Oat cell carcinoma may respond to
chemotherapy and stay in remission for at least a
fewmonths. Despitethistheprognosisispoorwith
an overall median survival ofone year.3 Our case
reports demonstrate and reiterate the aggressive
nature ofextra-pulmonary oat cell cancer and the
associated poor survival. Radical surgery has little
roleinthemanagementofthesepatientsandsurgery
is usually limited to palliation only.
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